# Antiplatelet Thrombolysin (Anfibatide) Phase 1 Clinical Trial in Healthy Volunteers

> **NCT04404790** · PHASE1 · SUSPENDED · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 50 (estimated)

## Conditions studied

- Antiplatelet Drug

## Interventions

- **DRUG:** Anfibatide 5 IU/60kg
- **DRUG:** Anfibatide 5 IU/60kg +0.002 IU/kg/h
- **DRUG:** Anfibatide 5 IU/60kg +0.004 IU/kg/h
- **DRUG:** Anfibatide 5 IU/60kg +0.008 IU/kg/h
- **DRUG:** Anfibatide 7 IU/60kg
- **DRUG:** Anfibatide 7 IU/60kg +0.002 IU/kg/h
- **DRUG:** Anfibatide 7 IU/60kg +0.004 IU/kg/h
- **DRUG:** Anfibatide 7 IU/60kg +0.008 IU/kg/h

## Key facts

- **NCT ID:** NCT04404790
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2020-09
- **Primary completion:** 2021-03
- **Final completion:** 2021-05
- **Target enrollment:** 50 (ESTIMATED)
- **Why stopped:** Optimization of protocol
- **Last updated:** 2020-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04404790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04404790, "Antiplatelet Thrombolysin (Anfibatide) Phase 1 Clinical Trial in Healthy Volunteers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04404790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*